What are the side effects of NAD+?
Quick answer
NAD+ side effects are generally mild. Subcutaneous injections may cause brief stinging at the site. IV infusions commonly cause flushing, chest tightness, and nausea during administration. Oral precursors occasionally cause GI discomfort. Serious adverse events are rare in published literature.
Injection side effects
Subcutaneous NAD+ injection is the best-tolerated route. The most common side effect is transient stinging or burning at the injection site, lasting 10-60 seconds. Some patients notice mild redness that resolves within hours.
Occasionally, patients report a brief flush (warmth and skin reddening) within 15-30 minutes of injection. This is related to NAD+'s role in vasodilation pathways and is not dangerous. Headache and mild nausea are reported rarely and typically only in the first few sessions.
IV infusion side effects
IV NAD+ produces more noticeable side effects because of the rapid delivery. During infusion, many patients experience chest tightness, abdominal cramping, flushing, and nausea. These are rate-dependent -- slowing the infusion rate reliably reduces symptoms.
The infusion rate typically starts at 1-2mg/minute and adjusts based on tolerance. Some clinics take 2-4 hours for a 500mg infusion to minimize these effects. Others push faster and manage symptoms with anti-nausea medication. All of these effects resolve when the infusion stops or slows.
Oral supplement side effects
NMN and NR supplements occasionally cause mild GI symptoms: stomach upset, bloating, or diarrhea. These are typically dose-dependent and improve with food. High-dose NMN (1000mg+) is more likely to cause GI discomfort than lower doses.
There's theoretical concern about high-dose niacin-related flushing with some NAD+ precursors, but NMN and NR are specifically chosen because they bypass the niacin flush pathway. If you experience flushing from an oral NAD+ supplement, the product may contain niacin or nicotinamide that shouldn't be there -- check your brand's purity testing.
What the safety data shows
Published clinical trials on NAD+ precursors (NMN, NR) up to 12 months show no serious adverse events at standard doses. Blood chemistry, liver function, and kidney function remain stable. The safety profile is favorable.
That said, long-term safety data beyond 2 years is limited. NAD+ supplementation is relatively new as a clinical intervention. The theoretical risks -- accelerated growth of existing cancers (NAD+ supports cellular metabolism, including cancer cell metabolism) -- have not materialized in human studies but are monitored in ongoing research. If you have a current cancer diagnosis, discuss NAD+ supplementation with your oncologist.
Learn more about NAD+
Frequently asked questions
Can NAD+ cause anxiety?
Some patients report temporary restlessness or a jittery feeling, particularly after IV infusions or the first few subcutaneous injections. This is not well-studied but may relate to increased cellular energy production. It typically fades within hours and diminishes with continued use.
Is NAD+ safe for long-term use?
Published data up to 12 months shows no safety signals. NAD+ is a naturally occurring molecule in every cell. Supplementation restores declining levels rather than introducing a foreign substance. Long-term studies beyond 2 years are still underway.
Can NAD+ interact with medications?
No major drug interactions are established for NAD+ supplementation. However, because NAD+ influences cellular metabolism broadly, inform your prescriber about all medications you take. Particular caution is warranted with immunosuppressants and chemotherapy agents.
Get the right protocol for your goals
Take a 2-minute quiz. Matched to your health profile by a licensed provider.